X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Whitepapers

Pharmacovigilance & Risk Management for Biosimilars: Unique Challenges & Possible Solutions

Yuvraj_pawp by Yuvraj_pawp
19th November 2015
in Whitepapers
Pharmacovigilance & Risk Management for Biosimilars: Unique Challenges & Possible Solutions

Biological medicines have made substantial contributions to the treatment of many chronic and serious diseases and are expected to provide significant therapeutic benefits to many patients who would otherwise have had limited treatment options.

Increasingly aging populations and this growing burden of chronic diseases have put tremendous pressure on healthcare systems all over the world, increasing demand for cost effective medicines.

This has opened up huge opportunities for follow-on biologics, or biosimilars, to enter the market and serve the needs of patients all over the world in a cost effective manner.

Click here to Download the White paper

Previous Post

Unique Patient Challenges and Support Solutions in Rare Disease

Next Post

Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

Related Posts

Whitepapers

The Future of Digital Health

21st February 2018
Five Best Practices to Deliver Exceptional Multichannel Experiences
Whitepapers

Five Best Practices to Deliver Exceptional Multichannel Experiences

19th November 2015
The Impact and Use of Social Media in Pharmacovigilance
Whitepapers

The Impact and Use of Social Media in Pharmacovigilance

19th November 2015
Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes
Whitepapers

Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

19th November 2015
Unique Patient Challenges and Support Solutions in Rare Disease
Whitepapers

Unique Patient Challenges and Support Solutions in Rare Disease

19th November 2015
Whitepapers

Environmental Nutrition – Redefining Healthy Food in the Health Care

18th November 2015
Next Post
Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

Leveraging Patient Feedback Data to Support Effectiveness and Demonstrate Outcomes

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In